236 related articles for article (PubMed ID: 23764000)
1. PDEF promotes luminal differentiation and acts as a survival factor for ER-positive breast cancer cells.
Buchwalter G; Hickey MM; Cromer A; Selfors LM; Gunawardane RN; Frishman J; Jeselsohn R; Lim E; Chi D; Fu X; Schiff R; Brown M; Brugge JS
Cancer Cell; 2013 Jun; 23(6):753-67. PubMed ID: 23764000
[TBL] [Abstract][Full Text] [Related]
2. AR-PDEF pathway promotes tumour proliferation and upregulates MYC-mediated gene transcription by promoting MAD1 degradation in ER-negative breast cancer.
Cao L; Xu C; Xiang G; Liu F; Liu X; Li C; Liu J; Meng Q; Jiao J; Niu Y
Mol Cancer; 2018 Sep; 17(1):136. PubMed ID: 30217192
[TBL] [Abstract][Full Text] [Related]
3. Clinical significance of PDEF factor expression and its relation to androgen receptor in ER
Cao L; Li C; Xu C; Xiang G; Liu F; Liu X; Jiao J; Lv S; Niu Y
Histopathology; 2018 Nov; 73(5):819-831. PubMed ID: 29969155
[TBL] [Abstract][Full Text] [Related]
4. Prostate-derived Ets factor, an oncogenic driver in breast cancer.
Sood AK; Geradts J; Young J
Tumour Biol; 2017 May; 39(5):1010428317691688. PubMed ID: 28468594
[TBL] [Abstract][Full Text] [Related]
5. Tip30 controls differentiation of murine mammary luminal progenitor to estrogen receptor-positive luminal cell through regulating FoxA1 expression.
Chen F; Li A; Gao S; Hollern D; Williams M; Liu F; VanSickle EA; Andrechek E; Zhang C; Yang C; Luo R; Xiao H
Cell Death Dis; 2014 May; 5(5):e1242. PubMed ID: 24853420
[TBL] [Abstract][Full Text] [Related]
6. Novel role for PDEF in epithelial cell migration and invasion.
Gunawardane RN; Sgroi DC; Wrobel CN; Koh E; Daley GQ; Brugge JS
Cancer Res; 2005 Dec; 65(24):11572-80. PubMed ID: 16357167
[TBL] [Abstract][Full Text] [Related]
7. Prostate derived ETS factor (PDEF): a putative tumor metastasis suppressor.
Steffan JJ; Koul HK
Cancer Lett; 2011 Nov; 310(1):109-17. PubMed ID: 21764212
[TBL] [Abstract][Full Text] [Related]
8. Prostate-derived Ets transcription factor overexpression is associated with nodal metastasis and hormone receptor positivity in invasive breast cancer.
Turcotte S; Forget MA; Beauseigle D; Nassif E; Lapointe R
Neoplasia; 2007 Oct; 9(10):788-96. PubMed ID: 17971898
[TBL] [Abstract][Full Text] [Related]
9. Prostate-derived Ets transcription factor (PDEF) downregulates survivin expression and inhibits breast cancer cell growth in vitro and xenograft tumor formation in vivo.
Ghadersohi A; Pan D; Fayazi Z; Hicks DG; Winston JS; Li F
Breast Cancer Res Treat; 2007 Mar; 102(1):19-30. PubMed ID: 16897429
[TBL] [Abstract][Full Text] [Related]
10. A high AR:ERα or PDEF:ERα ratio predicts a sub-optimal response to tamoxifen therapy in ERα-positive breast cancer.
Cao L; Xiang G; Liu F; Xu C; Liu J; Meng Q; Lyu S; Wang S; Niu Y
Cancer Chemother Pharmacol; 2019 Sep; 84(3):609-620. PubMed ID: 31297554
[TBL] [Abstract][Full Text] [Related]
11. Prostate derived Ets transcription factor and Carcinoembryonic antigen related cell adhesion molecule 6 constitute a highly active oncogenic axis in breast cancer.
Mukhopadhyay A; Khoury T; Stein L; Shrikant P; Sood AK
Oncotarget; 2013 Apr; 4(4):610-21. PubMed ID: 23592399
[TBL] [Abstract][Full Text] [Related]
12. ELF5 suppresses estrogen sensitivity and underpins the acquisition of antiestrogen resistance in luminal breast cancer.
Kalyuga M; Gallego-Ortega D; Lee HJ; Roden DL; Cowley MJ; Caldon CE; Stone A; Allerdice SL; Valdes-Mora F; Launchbury R; Statham AL; Armstrong N; Alles MC; Young A; Egger A; Au W; Piggin CL; Evans CJ; Ledger A; Brummer T; Oakes SR; Kaplan W; Gee JM; Nicholson RI; Sutherland RL; Swarbrick A; Naylor MJ; Clark SJ; Carroll JS; Ormandy CJ
PLoS Biol; 2012; 10(12):e1001461. PubMed ID: 23300383
[TBL] [Abstract][Full Text] [Related]
13. Prostate-derived ets factor represses tumorigenesis and modulates epithelial-to-mesenchymal transition in bladder carcinoma cells.
Tsui KH; Lin YH; Chung LC; Chuang ST; Feng TH; Chiang KC; Chang PL; Yeh CJ; Juang HH
Cancer Lett; 2016 May; 375(1):142-151. PubMed ID: 26965996
[TBL] [Abstract][Full Text] [Related]
14. Epigenetic modifications of prostate-derived Ets transcription factor in breast cancer cells.
Sabherwal Y; Mahajan N; Zhang M
Oncol Rep; 2013 Oct; 30(4):1985-8. PubMed ID: 23921628
[TBL] [Abstract][Full Text] [Related]
15. ARID1A determines luminal identity and therapeutic response in estrogen-receptor-positive breast cancer.
Xu G; Chhangawala S; Cocco E; Razavi P; Cai Y; Otto JE; Ferrando L; Selenica P; Ladewig E; Chan C; Da Cruz Paula A; Witkin M; Cheng Y; Park J; Serna-Tamayo C; Zhao H; Wu F; Sallaku M; Qu X; Zhao A; Collings CK; D'Avino AR; Jhaveri K; Koche R; Levine RL; Reis-Filho JS; Kadoch C; Scaltriti M; Leslie CS; Baselga J; Toska E
Nat Genet; 2020 Feb; 52(2):198-207. PubMed ID: 31932695
[TBL] [Abstract][Full Text] [Related]
16. Association of GATA3, P53, Ki67 status and vascular peritumoral invasion are strongly prognostic in luminal breast cancer.
Jacquemier J; Charafe-Jauffret E; Monville F; Esterni B; Extra JM; Houvenaeghel G; Xerri L; Bertucci F; Birnbaum D
Breast Cancer Res; 2009; 11(2):R23. PubMed ID: 19405945
[TBL] [Abstract][Full Text] [Related]
17. Proteomic analysis of a PDEF Ets transcription factor-interacting protein complex.
Cho JY; Lee M; Ahn JM; Park ES; Cho JH; Lee SJ; Kim BG; Heo SH; Park HJ; Zerbini LF; Hwang D; Libermann TA
J Proteome Res; 2009 Mar; 8(3):1327-37. PubMed ID: 19203193
[TBL] [Abstract][Full Text] [Related]
18. Global gene expression analysis identifies PDEF transcriptional networks regulating cell migration during cancer progression.
Turner DP; Findlay VJ; Kirven AD; Moussa O; Watson DK
Mol Biol Cell; 2008 Sep; 19(9):3745-57. PubMed ID: 18579687
[TBL] [Abstract][Full Text] [Related]
19. Prostate-Derived Ets Factor (PDEF) Inhibits Metastasis by Inducing Epithelial/Luminal Phenotype in Prostate Cancer Cells.
Wang F; Koul S; Shanmugam PST; Dong Q; Koul HK
Mol Cancer Res; 2018 Sep; 16(9):1430-1440. PubMed ID: 29848555
[TBL] [Abstract][Full Text] [Related]
20. FOXA1 represses the molecular phenotype of basal breast cancer cells.
Bernardo GM; Bebek G; Ginther CL; Sizemore ST; Lozada KL; Miedler JD; Anderson LA; Godwin AK; Abdul-Karim FW; Slamon DJ; Keri RA
Oncogene; 2013 Jan; 32(5):554-63. PubMed ID: 22391567
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
